Acorda Therapeutics (ACOR)

Add to Watchlists Create an Alert
32.67 +0.44  +1.37%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Acorda Therapeutics Revenue Quarterly:

71.86M for Dec. 31, 2012
View Full Chart

Acorda Therapeutics Revenue Quarterly Chart

    Acorda Therapeutics Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 71.86M
    Dec. 31, 2012 81.47M
    Sept. 30, 2012 77.44M
    June 30, 2012 75.66M
    March 31, 2012 71.25M
    Dec. 31, 2011 72.64M
    Sept. 30, 2011 93.03M
    June 30, 2011 65.28M
    March 31, 2011 61.29M
    Dec. 31, 2010 66.80M
    Sept. 30, 2010 63.62M
    June 30, 2010 42.84M
    March 31, 2010 17.75M
    Dec. 31, 2009 14.44M
    Sept. 30, 2009 15.21M
    June 30, 2009 12.55M
       
    March 31, 2009 12.47M
    Dec. 31, 2008 12.46M
    Sept. 30, 2008 12.47M
    June 30, 2008 11.39M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    Sept. 30, 2003 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    ACOR Revenue Quarterly Benchmarks

    Companies
    Discovery Laboratories 0.072M
    Biogen Idec 1.415B
    Osiris Therapeutics 4.241M

    ACOR Revenue Quarterly Rankings

    Overall 66th percentile
    2714 of 8011
    Sector 73rd percentile
    181 of 687 in Healthcare
    Industry 91st percentile
    22 of 248 in Biotechnology

    ACOR Revenue Quarterly Range, Past 5 Years

    Minimum 11.39M Jun 2008
    Maximum 93.03M Sep 2011
    Average 47.60M